Bangladesh, India discuss modalities of conducting clinical trials of Covid-19 vaccine
Bangladesh and India had “fruitful discussions” on modalities of conducting clinical trials in Bangladesh for Covid-19 vaccine development.
Anurag Srivastava, spokesman of India’s External Affairs Ministry, told the weekly media briefing in New Delhi that an Indian delegation of concerned departments had visited Bangladesh during October 17-19 and had “fruitful discussions” with their Bangladeshi counterparts on the current stage of vaccine development in India and modalities of clinical trials in Bangladesh, reports our New Delhi correspondent.
India has already sent two training modules for its neighbouring countries involving 90 health experts and scientists.
India and Bangladesh are also in discussion over capacity-building, cold storage and Covid-19 vaccine development, Srivastava said in reply to a question.
India’s cooperation with Bangladesh in vaccine development and capacity-building is in line with Indian Prime Minister Narendra Modi’s assurance to the UN General Assembly in September that his country’s vaccine production and delivery capacity would be used to help all humanity in fighting the Covid-19 pandemic.
“As the situation with respect to vaccine development evolves, the sides will discuss and decide on modalities of cooperation,” the MEA spokesman said.
Depending on the trials in India, the country has proposed to expand its cooperation with other countries in clinical trials and capacity-building for vaccine development, production and delivery, he added.